Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ABBOTT LABORATORIES
2013ABBOTT LABORATORIES : Abbott Declares 359th Consecutive Quarterly Dividend
PR
2013ABBOTT LABORATORIES : Abbott Named the Leading Healthcare Company on the Dow Jones Sustain..
PR
2013ABBOTT LABORATORIES : New Data Suggests Abbott's High Sensitive Troponin Test May Help Doc..
PU
2013ABBOTT LABORATORIES : Oral Nutritional Supplements in the Hospital Demonstrate Significant..
PU
2013ABBOTT LABORATORIES : Abbott Completes Acquisition of IDEV Technologies
PR
2013ABBOTT LABORATORIES : Abbott Completes Acquisition of OptiMedica
PR
2013ABBOTT LABORATORIES : New Data for Abbott’s Investigational High Sensitive Troponin Test S..
PU
2013ABBOTT LABORATORIES : Abbott Features Solutions to Help Labs Prepare for the Evolving Heal..
PU
2013ABBOTT LABORATORIES : Abbott Receives FDA Clearance for FreeStyle Precision Pro Blood Gluc..
PU
2013ABBOTT LABORATORIES : Abbott Receives FDA Clearance for FreeStyle Precision Pro Blood Gluc..
PR
2013ABBOTT LABORATORIES : Abbott Reports Second-Quarter 2013 Results
PR
2013ABBOTT LABORATORIES : Abbott to Enter Laser Cataract Surgery Market through Acquisition of..
PR
2013ABBOTT LABORATORIES : Abbott to Acquire IDEV Technologies to Expand Global Peripheral Tech..
PR
2013ABBOTT LABORATORIES : Abbott Announces Approval of Next-Generation XIENCE Xpedition™ Drug ..
PU
2013ABBOTT LABORATORIES : Abbott Announces Approval of Next-Generation XIENCE Xpedition(TM) Dr..
PR
2013ABBOTT LABORATORIES : Abbott Hosts Conference Call for Second-Quarter Earnings
PR
2013ABBOTT LABORATORIES : Abbott Recognizes Winners of Supplier Excellence Awards
PU
2013ABBOTT LABORATORIES : Abbott Announces New Test to Help Doctors Determine Personalized Tre..
PU
2013ABBOTT LABORATORIES : Abbott Announces New $3 Billion Share Repurchase Program, Declares D..
PR
2013ABBOTT LABORATORIES : Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the ..
PR
2013ABBOTT LABORATORIES : Abbott to Present at Wells Fargo Securities Research & Economics 201..
PR
2013ABBOTT LABORATORIES : Two Real-World European Studies of Abbott's Minimally Invasive Mitra..
PU
2013ABBOTT LABORATORIES : Abbott to Present at William Blair 33rd Annual Growth Stock Conferen..
PR
2013ABBOTT LABORATORIES : Abbott Previews Next-Generation Blood Screening Prototype during Int..
PU
2013ABBOTT LABORATORIES : Abbott to Present at Goldman Sachs 34th Annual Global Healthcare Con..
PR
2013ABBOTT LABORATORIES : Abbott to Present at Deutsche Bank 38th Annual Health Care Conferenc..
PR
2013ABBOTT LABORATORIES : Abbott Announces CE Mark for World's Longest Coronary Drug Eluting S..
PU
2013ABBOTT LABORATORIES : Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and..
PR
2013ABBOTT LABORATORIES : Abbott to Present at UBS Global Healthcare Conference
PR
2013ABBOTT LABORATORIES : Abbott Announces FDA Approval and U.S. Launch of the TECNIS® Toric I..
PU
2013ABBOTT LABORATORIES : Abbott Reports First-Quarter 2013 Results
PR
2013ABBOTT LABORATORIES : Abbott Introduces Next Generation Laboratory Automation Solution to ..
PR
2013ABBOTT LABORATORIES : Abbott Initiates Voluntary Recall of FreeStyle InsuLinx® Blood Gluco..
PR
2013ABBOTT LABORATORIES : Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool fo..
PU
2013ABBOTT LABORATORIES : Abbott Hosts Conference Call for First-Quarter Earnings
PR
2013ABBOTT LABORATORIES : New Abbott Test Can Help Doctors Detect the Presence of Two Importan..
PR
2013ABBOTT LABORATORIES : FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasiv..
PU
2013ABBOTT LABORATORIES : FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasiv..
PR
2013ABBOTT LABORATORIES : New Data Reinforce Strong Long-Term Clinical Performance of Abbott's..
PU
2013ABBOTT LABORATORIES : Abbott's Minimally Invasive MitraClip ® System for Mitral Regurgitat..
PU
2013ABBOTT LABORATORIES : Abbott to Present at Barclays Capital 2013 Global Healthcare Confere..
PR
2013ABBOTT LABORATORIES : Abbott Introduces Nutrition for Active Kids - Kidz ZonePerfect® Nutr..
PU
2013ABBOTT LABORATORIES : Abbott Introduces Nutrition for Active Kids - Kidz ZonePerfect(R) Nu..
PR
2013ABBOTT LABORATORIES : Abbott to Collaborate with Janssen and Pharmacyclics on Development ..
PU
2013ABBOTT LABORATORIES : Abbott Declares 357th Consecutive Quarterly Dividend
PR
2013ABBOTT LABORATORIES : New Survey Reveals Eight in 10 Fitness Enthusiasts Are Not Doing Eno..
PR
2013ABBOTT LABORATORIES : Abbott Reports Fourth-Quarter and Full-Year 2012 Results
PR
2013ABBOTT LABORATORIES : Abbott and AbbVie Named to S&P Dividend Aristocrats Indices
PR
2013ABBOTT LABORATORIES : Abbott and AbbVie Announce Investor Calls
PU
2013ABBOTT LABORATORIES : Abbott Initiates Clinical Trial of Absorb™ in the United States
PU
2013ABBOTT LABORATORIES : New Abbott Test Available in Europe Provides Novel Tool to Aid Docto..
PR
2013ABBOTT LABORATORIES : Abbott Initiates Clinical Trial of Absorb(TM) in the United States
PR
2013ABBOTT LABORATORIES : Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIE..
PU
2013ABBOTT LABORATORIES : Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIE..
PR
2013ABBOTT LABORATORIES : Abbott Completes Separation of Research-Based Pharmaceuticals Busine..
PR
2012ABBOTT LABORATORIES : Abbott and AbbVie to Present at Financial Conferences
PR
2012ABBOTT LABORATORIES : AbbVie Inc. Common Stock Approved for Listing on NYSE Euronext Paris
PU
2012ABBOTT LABORATORIES : Abbott Announces New Testosterone Test to Measure the Hormone at Low..
PR
2012ABBOTT LABORATORIES : Abbott Declares 356th Consecutive Quarterly Dividend
PR
2012ABBOTT LABORATORIES : New Study Shows Promising Results For Tests That Can Help Doctors Be..
PU
2012ABBOTT LABORATORIES : Elotuzumab Progression-Free Survival Data from Phase 2 Study of Pati..
BU
2012ABBOTT LABORATORIES : Abbott Announces Effectiveness of AbbVie Form 10 Registration Statem..
PR
2012ABBOTT LABORATORIES : Abbott Board of Directors Approves Separation of AbbVie and Declares..
PR
2012ABBOTT LABORATORIES : Abbott Announces Final Results for Partial Debt Tender Offers
PR
2012ABBOTT LABORATORIES : Abbott’s HUMIRA® (Adalimumab) Approved in Europe for Severe Active P..
PU
2012ABBOTT LABORATORIES : Sucampo and Abbott Announce Launch of AMITIZA in Japan
BU
2012ABBOTT LABORATORIES : Abbott Announces Phase 3 Hepatitis C Program Details
PU
2012ABBOTT LABORATORIES : Abbott Announces Results for Any and All Debt Tender Offers
PR
2012ABBOTT LABORATORIES : Abbott Announces Results of Analysis Exploring the Use of HUMIRA® (A..
PU
2012ABBOTT LABORATORIES : Abbott Announces First Long-term Patient-reported Health Outcomes Da..
PU
2012ABBOTT LABORATORIES : Abbott Presents Promising Phase 2b Interferon-free Hepatitis C Resul..
PU
2012ABBOTT LABORATORIES : Abbott Announces Early Tender Results for Partial Debt Tender Offers..
PR
2012ABBOTT LABORATORIES : Abbott Announces Consideration for Debt Tender Offers
PR
2012ABBOTT LABORATORIES : Abbott Announces Pricing of AbbVie's $14.7 Billion Private Placement..
PR
2012ABBOTT LABORATORIES : Statement: Abbott and the Abbott Fund Donate $1 Million in Funding a..
PU
Prev.4  5  6  7  8   9  10  11  12  13Next
Upcoming event on ABBOTT LABORATORIES